Transcriptomic analysis associated with reversal of cisplatin sensitivity in drug resistant osteosarcoma cells after a drug holiday
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Transcriptomic analysis associated with reversal of cisplatin sensitivity in drug resistant osteosarcoma cells after a drug holiday ; volume:19 ; number:1 ; day:5 ; month:11 ; year:2019 ; pages:1-14 ; date:12.2019
BMC cancer ; 19, Heft 1 (5.11.2019), 1-14, 12.2019
- Urheber
-
Niveditha, Divya
Sharma, Harshita
Majumder, Syamantak
Mukherjee, Sudeshna
Chowdhury, Rajdeep
Chowdhury, Shibasish
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-019-6300-2
- URN
-
urn:nbn:de:101:1-2020030222520825777664
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Niveditha, Divya
- Sharma, Harshita
- Majumder, Syamantak
- Mukherjee, Sudeshna
- Chowdhury, Rajdeep
- Chowdhury, Shibasish
- SpringerLink (Online service)
Ähnliche Objekte (12)
Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug Cisplatin
Drug holidays in der psychopharmakologischen Langzeittherapie
HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma
Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Action of the anticancer drug cisplatin investigated by molecular simulation
Action of the anticancer drug cisplatin investigated by molecular simulation
Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma Cells
In vivo therapy of osteosarcoma using anion transporters-based supramolecular drugs
Anticancer activity of drug-loaded calcium phosphate nanocomposites against human osteosarcoma
Recent advances in drug delivery systems for osteosarcoma therapy and bone regeneration
Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug Cisplatin
Drug holidays in der psychopharmakologischen Langzeittherapie
HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma
Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Action of the anticancer drug cisplatin investigated by molecular simulation
Action of the anticancer drug cisplatin investigated by molecular simulation
Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma Cells
In vivo therapy of osteosarcoma using anion transporters-based supramolecular drugs
Anticancer activity of drug-loaded calcium phosphate nanocomposites against human osteosarcoma
Recent advances in drug delivery systems for osteosarcoma therapy and bone regeneration
Melatonin Increases the Sensitivity of Osteosarcoma Cells to Chemotherapy Drug Cisplatin
Drug holidays in der psychopharmakologischen Langzeittherapie
HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma
Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Action of the anticancer drug cisplatin investigated by molecular simulation
Action of the anticancer drug cisplatin investigated by molecular simulation
Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics
Targeting CD44 by CRISPR-Cas9 in Multi-Drug Resistant Osteosarcoma Cells
In vivo therapy of osteosarcoma using anion transporters-based supramolecular drugs
Anticancer activity of drug-loaded calcium phosphate nanocomposites against human osteosarcoma